| Summary Of Additional Information On Company's Net loss Including Segment Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Research and development expense |
|
|
|
|
|
|
|
|
|
|
|
LX2006 |
$ |
12,660 |
|
|
$ |
5,135 |
|
|
$ |
26,104 |
|
|
$ |
12,072 |
|
LX2020 |
|
2,746 |
|
|
|
3,137 |
|
|
|
5,753 |
|
|
|
12,058 |
|
Other programs |
|
1,569 |
|
|
|
845 |
|
|
|
4,334 |
|
|
|
2,192 |
|
Employee compensation expenses |
|
3,847 |
|
|
|
3,374 |
|
|
|
11,703 |
|
|
|
11,833 |
|
Lab-related costs and supplies |
|
558 |
|
|
|
449 |
|
|
|
1,553 |
|
|
|
1,128 |
|
Acquired in-process research and development |
|
9,874 |
|
|
|
- |
|
|
|
9,874 |
|
|
|
- |
|
All other research and development expense |
|
3,242 |
|
|
|
2,755 |
|
|
|
9,905 |
|
|
|
8,304 |
|
General and administrative expense |
|
|
|
|
|
|
|
|
|
|
|
Employee compensation expenses |
|
2,165 |
|
|
|
1,867 |
|
|
|
6,124 |
|
|
|
6,156 |
|
All other general and administrative expense |
|
3,738 |
|
|
|
4,086 |
|
|
|
15,402 |
|
|
|
32,398 |
|
Other income and expense, net |
|
(2,099 |
) |
|
|
(1,365 |
) |
|
|
(6,389 |
) |
|
|
(7,099 |
) |
Net loss |
$ |
(38,300 |
) |
|
$ |
(20,283 |
) |
|
$ |
(84,363 |
) |
|
$ |
(79,042 |
) |
|